AI

Allostery Investments Portfolio holdings

AUM $7.85M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$69.3M
AUM Growth
+$18.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
55
New
Increased
Reduced
Closed

Top Buys

1
+$4.49M
2
+$3.44M
3
+$2.7M
4
PLRX icon
Pliant Therapeutics
PLRX
+$2.68M
5
PCVX icon
Vaxcyte
PCVX
+$2.56M

Top Sells

1
+$982K
2
+$905K
3
+$545K
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$496K
5
JSPR icon
Jasper Therapeutics
JSPR
+$470K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
26
Pliant Therapeutics
PLRX
$86.6M
$596K 0.86%
+441,686
CNTX icon
27
Context Therapeutics
CNTX
$284M
$582K 0.84%
950,166
PHGE icon
28
BiomX
PHGE
$10.2M
$523K 0.75%
49,507
+15,621
RLYB icon
29
Rallybio
RLYB
$50.8M
$492K 0.71%
94,029
-6,396
ELDN icon
30
Eledon Pharmaceuticals
ELDN
$217M
$339K 0.49%
100,000
CLYM
31
Climb Bio
CLYM
$347M
$299K 0.43%
244,988
ORKA
32
Oruka Therapeutics
ORKA
$1.55B
$205K 0.3%
20,000
MDGL icon
33
Madrigal Pharmaceuticals
MDGL
$9.96B
$199K 0.29%
+600
ETNB
34
DELISTED
89bio
ETNB
$182K 0.26%
+25,000
PMN icon
35
ProMIS Neurosciences
PMN
$42.9M
$165K 0.24%
9,348
+1,544
LEGN icon
36
Legend Biotech
LEGN
$3.52B
$161K 0.23%
+4,750
VIR icon
37
Vir Biotechnology
VIR
$1.52B
$144K 0.21%
+22,202
WVE icon
38
Wave Life Sciences
WVE
$2.51B
$141K 0.2%
+17,500
ARQT icon
39
Arcutis Biotherapeutics
ARQT
$2.84B
$117K 0.17%
+7,500
EWTX icon
40
Edgewise Therapeutics
EWTX
$3.21B
$66K 0.1%
+3,000
LXEO icon
41
Lexeo Therapeutics
LXEO
$484M
$17.5K 0.03%
5,054
ANAB icon
42
AnaptysBio
ANAB
$1.83B
– –
0
APLS icon
43
Apellis Pharmaceuticals
APLS
$2.35B
– –
0
CRNX icon
44
Crinetics Pharmaceuticals
CRNX
$3.82B
– –
-9,700
DNTH icon
45
Dianthus Therapeutics
DNTH
$3.47B
– –
-25,000
ELEV
46
DELISTED
Elevation Oncology
ELEV
– –
-432,206
JSPR icon
47
Jasper Therapeutics
JSPR
$35.5M
– –
-22,000
DFTX
48
Definium Therapeutics
DFTX
$1.79B
– –
-130,000
NVAX icon
49
Novavax
NVAX
$1.68B
– –
0
OLMA icon
50
Olema Pharmaceuticals
OLMA
$1.2B
– –
0
1
2
3